MATAWAN, N.J., Jan 08, 2008 (BUSINESS WIRE) -- PacificHealth Laboratories, Inc. (PHLI) , a nutrition technology company, today announced the appointment of Matthew Spolar, age 34, as the Company's Vice President of Product Development & Supply Chain, effective January 3, 2008.
Prior to joining PacificHealth Laboratories, Mr. Spolar served as Vice President of Product Technology at Atkins Nutritionals, Inc. where he was the architect of a highly successful new product development program that helped the company increase its revenues from $40 million to over $650 million in less than four years. More recently, Mr. Spolar was integrally involved with the strategic restructuring at Atkins Nutritionals, Inc. that culminated with a successful acquisition of its controlling interest by North Castle Partners, LLC in Sept. 2007. In addition to his work at Atkins, Matt has served on the Board of Directors of OXIS International, Inc., a publicly traded biotechnology company focused on unique proprietary assays that help diagnose diseases associated with oxidative stress. Mr. Spolar received his Bachelors of Science and Master of Sciences degrees in Food Science from Pennsylvania State University.
Dr. Robert Portman, Chairman and CEO of PacificHealth Laboratories, said, "Over the past year, we have significantly increased the depth of our management team that has been tasked with developing and executing a comprehensive growth strategy. Matt has a proven track record of spearheading similar growth initiatives, particularly in the weight loss and nutrition areas."
Jason Ash, President and Chief Operating Officer of PacificHealth Laboratories, added, "Matt has a long and successful history in our business' categories, and I speak for the entire team when I say we look forward to leveraging his knowledge and abilities to accelerate the growth of PHLI."
Matthew Spolar, newly appointed Vice President of Product Development & Supply Chain, concluded, "PacificHealth is at an important inflection point in its history and I am excited and committed to working with the team to ensure that we continue to develop and efficiently deliver the best products to the marketplace."
About PacificHealth Laboratories, Inc.
PacificHealth Laboratories, Inc. (PHLI.OB), a leading nutrition technology company, has been a pioneer in discovering, developing and commercializing patented, protein-based nutritional products that stimulate specific peptides involved in appetite regulation and that activate biochemical pathways involved in muscle performance and growth. PHLI's principle areas of focus include weight loss, management of Type 2 diabetes and sports performance. To learn more, visit www.pacifichealthlabs.com.
Notice: This news release and oral statements made from time to time by Company representatives concerning the same subject matter may contain so-called "forward-looking statements." These statements can be identified by introductory words such as "expects," "plans," "will," "estimates," "forecasts," "projects" or words of similar meaning and by the fact they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing new products and their potential. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known, such general economic conditions, consumer product acceptance and competitive products, and others of which are not. No forward-looking statements are a guarantee of future results or events, and one should avoid placing undue reliance on such statements.